Fragmento

During the last decade the pay-for-performance paradigm has increasingly attracted the interest of all parts involved in health care systems. There is no clear information about how will this affect in the short-term the quality of those systems. Despite improvement in quality indicators at patient-level from quasi experimental studies,2 it is difficult to demonstrate if this paradigm would deeply improve medical and non-medical processes in real life sceneries. Moreover, real data from specific settings in which the pay-for-performance strategy is used, demonstrates an almost null correlation between the size of the economic benefit and the expected health gain. This could suggest that an expected health gain may increase the risk of skewing activity towards areas with high workload but relatively low benefits for health.

Palabras clave:

2012-06-12   |   676 visitas   |   Evalua este artículo 1 valoraciones

Vol. 11 Núm.4. Julio-Agosto 2012 Pags. 424-425 Ann Hepatol 2012; 11(4)